Biotricity Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Waqaas Al-Siddiq
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 41.4% |
| CEO tenure | 9.8yrs |
| CEO ownership | 8.3% |
| Management average tenure | no data |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding
Jan 26
Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)
Oct 26Biotricity GAAP EPS of -$0.09, revenue of $2.06M
Aug 15Biotricity, Inc.: A First Take
Jul 28Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?
Apr 09Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?
Dec 11Biotricity: Capital Raise Leads To Buying Opportunity
Aug 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$17m |
| Jun 30 2023 | n/a | n/a | -US$18m |
| Mar 31 2023 | US$1m | US$480k | -US$20m |
| Dec 31 2022 | n/a | n/a | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$23m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | US$887k | US$480k | -US$30m |
| Dec 31 2021 | n/a | n/a | -US$30m |
| Sep 30 2021 | n/a | n/a | -US$27m |
| Jun 30 2021 | n/a | n/a | -US$19m |
| Mar 31 2021 | US$891k | US$390k | -US$16m |
| Dec 31 2020 | n/a | n/a | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$14m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | US$2m | US$390k | -US$11m |
| Dec 31 2019 | n/a | n/a | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | US$2m | US$360k | -US$9m |
| Dec 31 2018 | n/a | n/a | -US$10m |
| Sep 30 2018 | n/a | n/a | -US$9m |
| Jun 30 2018 | n/a | n/a | -US$9m |
| Mar 31 2018 | US$1m | US$310k | -US$9m |
Compensation vs Market: Waqaas's total compensation ($USD1.16M) is above average for companies of similar size in the US market ($USD681.24K).
Compensation vs Earnings: Waqaas's compensation has increased whilst the company is unprofitable.
CEO
Waqaas Al-Siddiq (38 yo)
9.8yrs
Tenure
US$1,160,757
Compensation
Dr. Waqaas Al-Siddiq, PhD, has founded Biotricity Inc.(formerly known as iMedical Innovations Inc.) in July 2014 and has been its Chairman, President and Chief Executive Officer since July 2014. Dr. Al-Sid...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.8yrs | US$1.16m | 8.29% $ 1.2m | |
| Chair of Scientific & Medical Alliance Board and Chair of Science Alliance Board | 4.1yrs | no data | no data | |
| Member of the Board of Advisors | 7.9yrs | no data | no data | |
| Independent Director | 1.9yrs | US$14.67k | 0% $ 0 | |
| Independent Director | 7.9yrs | US$58.00k | 0% $ 0 | |
| Member of the Board of Advisors | 7.8yrs | no data | no data | |
| Member of the Board of Advisors | 7.9yrs | no data | no data | |
| Member of the Board of Advisors | 7.8yrs | no data | no data | |
| Member of Scientific & Medical Alliance Board | 5.4yrs | no data | no data | |
| Member of Scientific & Medical Alliance Board | 5.4yrs | no data | no data | |
| Member of Scientific & Medical Alliance Board | 5.4yrs | no data | no data | |
| Member of Scientific & Medical Alliance Board | 5.4yrs | no data | no data |
6.6yrs
Average Tenure
63yo
Average Age
Experienced Board: BTCY's board of directors are considered experienced (6.6 years average tenure).